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Abstract: BACKGROUND: Postnasal Drip (PND) is a common symptom associated with upper respi-
ratory tract disorders. It occurs without other symptoms or combined with chronic rhinosinusitis (CRS).
However, the pathophysiology of PND is debated to this day and an objective definition of PND has not
been established. Therefore we aimed to elucidate whether the viscosity and volume of nasal secretions
as well as the mucociliary clearance and sensitivity of the nasopharynx, or atopy could play a role in
the pathophysiology of PND. METHODS: A prospective case-control study of 30 patients - 15 PND and
15 healthy subjects - was conducted. The viscosity and volume of nasal secretions, the nasopharyngeal
sensitivity, the mucociliary clearance, and allergic sensitisation using a skin prick test (SPT) were as-
sessed in all subjects. RESULTS: Viscosity of nasal secretions in PND patients was significantly increased
compared to healthy subjects. Two follow-up measurements in symptom-free intervals showed reversibil-
ity of increased viscosity. Analysis of nasopharyngeal sensitivity showed significant reductions in PND
patients. Furthermore, mucociliary clearance seems to be prolonged in PND patients. The volume of
nasal secretions and the atopy screening showed no significant differences in PND compared to healthy
individuals. CONCLUSION: Increased viscosity seems to play a relevant role in the pathophysiology of
PND. Additionally, delayed mucociliary clearance as well as hyposensitivity of the nasopharynx may be
further components. Earlier concepts of PND, regarding an increased volume of secretions and atopy, do
not seem to hold true since our analyses showed no significant difference between cases and controls.
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Background: Postnasal Drip (PND) is a common symptom associated with upper respiratory tract disorders. It 32 
occurs without other symptoms or combined with chronic rhinosinusitis (CRS). However, the pathophysiology of 33 
PND is debated to this day and an objective definition of PND has not been established. Therefore we aimed to 34 
elucidate whether the viscosity and volume of nasal secretions as well as the mucociliary clearance and 35 
sensitivity of the nasopharynx, or atopy could play a role in the pathophysiology of PND.  36 
 37 
Methods: A prospective case-control study of 30 patients – 15 PND and 15 healthy subjects – was conducted. 38 
The viscosity and volume of nasal secretions, the nasopharyngeal sensitivity, the mucociliary clearance, and 39 
allergic sensitisation using a skin prick test (SPT) were assessed in all subjects. 40 
  41 
Results: Viscosity of nasal secretions in PND patients was significantly increased compared to healthy subjects. 42 
Two follow-up measurements in symptom-free intervals showed reversibility of increased viscosity. Analysis of 43 
nasopharyngeal sensitivity showed significant reductions in PND patients. Furthermore, mucociliary clearance 44 
seems to be prolonged in PND patients. The volume of nasal secretions and the atopy screening showed no 45 
significant differences in PND compared to healthy individuals.  46 
 47 
Conclusion: Increased viscosity seems to play a relevant role in the pathophysiology of PND. Additionally, 48 
delayed mucociliary clearance as well as hyposensitivity of the nasopharynx may be further components. Earlier 49 
concepts of PND, regarding an increased volume of secretions and atopy, do not seem to hold true since our 50 
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Postnasal Drip (PND) is an imprecise diagnosis. Its pathophysiology, as first described by Dobell in 1866 
(1)
, is 55 
debated to this day. Nevertheless, PND is a common symptom associated with upper respiratory tract disorders. 56 
Diagnosis of PND basically relies on the patient’s reporting of something dripping down into the throat, foreign 57 
body sensation in the throat, chronic cough, nasal discharge, or frequent throat clearing. Furthermore, on 58 
examination of the naso- or oropharynges the presence of mucoid or mucopurulent secretions is often seen. PND 59 
occurs without other symptoms or combined with other upper respiratory tract disorders. However, its 60 
pathophysiology is not definitely clarified yet. The concept of an increased fluid volume running from the 61 
posterior nasal choanae into the posterior naso- or oropharynx seems to be too simplified. As Rimmer and 62 
colleagues postulated, the pathophysiology of PND could also be associated with altered viscosity of nasal 63 
secretions or sensory dysfunction of the nasopharynx due to mucosal inflammation but no evidence was 64 
provided 
(2)
. The viscosity and elasticity are the fundamental rheological properties of nasal mucus 
(3)
, and are 65 
important determinants of transportability of mucus in the mucociliary system 
(4,5)
. Viscosity describes the 66 
capacity to respond to deforming forces by flowing, whereas elasticity refers to the ability to resist deformation 67 
by storing energy and recoiling. Since we focused on viscosity of nasal secretions other rheological terms such 68 
as complex modulus are not further discussed. 69 
Nasal glands and goblet cells are mainly responsible for the production of nasal secretion, while there is also a 70 
contribution from plasma exudation in the inflammatory state 
(2)
. Nasal mucus contains 95% water, 2.5% 71 
glycoproteins, 1-2% electrolytes and other proteins such as lysozyme, lactoferrin, and complement 
(6)
. Further 72 
contents may be tears as well as condensed exhaled water – the relative contributions of each are unknown 
(2)
. 73 
The viscosity of nasal secretions results from factors including the degree of hydration and the extent of cross 74 
linkages of mucus glycoproteins such as fucose and sialic acid.  75 
An additional hypothesis is that delayed mucociliary clearance, inability to produce proper nasal secretions, as 76 
well as atopic sensitization are jointly responsible for the sensation of PND. Since viscosity and mucociliary 77 
clearance negatively correlates with each other
 (7,8)
, this hypothesis seems to be plausible. We therefore 78 
postulated in our hypothesis that an altered viscosity of nasal secretions, a changed sensitivity – in line with a 79 
sensory dysfunction – and a prolonged mucociliary clearance result in the clinical symptoms of PND.  80 
The aims of this study were fivefold: to assess whether the viscosity and volume of nasal secretions, the 81 
mucociliary clearance and sensitivity of the nasopharynx, as well as the allergic sensitisation are different in 82 





















MATERIALS AND METHODS 84 
Ethics 85 
Informed consent was obtained from every patient, and this study was approved by Swiss Ethics Committees on 86 
research involving humans (ID: KEK 2018-00603). It was conducted in compliance with formalities of the 87 
independent ethical commission, the current Helsinki-Declaration as well as the Swiss law.  88 
 89 
Study Design and Population 90 
This monocentric prospective case-control study of patients with PND was conducted at the Department of 91 
Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich. The study population consisted of 15 92 
patients with typical symptoms of PND. All of these patients were required to report fluid dripping down into 93 
their throat in addition to at least two other typical PND symptoms such as foreign body sensation in the throat, 94 
chronic cough, nasal discharge, or frequent throat clearing. These symptoms have also been the reason they were 95 
seeking medical assistance for. Only chronic PND patients were recruited from outpatient clinics at the 96 
University Hospital Zurich and examined by the same trained examiner (S.B). To be eligible, participants were 97 
required to be aged between 18 and 70 years and able to give written consent. Exclusion criteria for all 98 
participants were current nasal medication, neoplasia of the naso- or oropharynx as well as acute states of PND.  99 
The control group comprised 15 patients without any nasal symptoms especially without any PND symptoms as 100 
described above. It was matched for age and sex (Table 1).  101 
All patients were asked about their medication and its potential influence on nasal secretions or one of the other 102 
parameters analyzed was evaluated. Therefore, all patients withheld oral cortisone for at least two weeks and 103 
intranasal cortisone as well as antihistamines for 48 hours. Comorbidities of all patients were recorded and 104 
specifically assessed for diseases influencing nasal secretions, mucociliary clearance or sensitivity in the 105 
nasopharynx such as cystic fibrosis or primary ciliary dysfunction. If patients underwent functional lung tests, 106 
results were noted. Since all our patients were adults, chloride sweat tests were not regularly performed. 107 
 108 
Data Collection 109 





















Mucociliary clearance of the nasopharynx was examined in all individuals using the saccharine transit test (STT) 111 
(9)
. The STT measures the elapsed time between saccharine deposition 2 cm inside the non-obstructed nostril and 112 
the first perception of a sweet taste in the mouth or oropharynx. Patients were evaluated under standardized 113 
conditions with ambient temperature at 21-23 °C and 58-67% relative humidity. The subjects remained in a 114 
seated position throughout the examination. Patients were instructed to maintain normal ventilation and to avoid 115 
sniffing, coughing, sneezing, deep breaths or talking during the test. A normal value for a healthy adult is 116 
described as less than 12 minutes 
(9–12)
. In case the STT exceeded 20 minutes, the test was stopped and a specific 117 
note in the case report form was taken.  118 
 119 
Skin Prick Test 120 
SPT were performed with a commercial standard protocol (house dust mite such as Dermatophagoides 121 
pteronyssinus and Dermatophagoides farinae, cockroach, dog hair, cat epithelium, horsehair, Alternaria 122 
alternata, Penicillium penicillium, Candida albicans, Cladosporium herbarum, grass-mix, mugwort-, birch-, 123 
alder-, ash-, hazel- and rye pollen, and ragweed) (ALK-Abelló). Solutions of 0.9% saline and 0.01% histamine 124 
hydrochloride (ALK-Abelló) served as negative and positive control, respectively. SPTs were conducted in 125 
double on the volar forearm applied in opposite directions and evaluated after 20 minutes, as described 
(13)
. 126 
Reactions were considered positive when a mean wheal diameter of >4 mm was seen.  127 
 128 
 Collection and Viscosity of Mucus  129 
The nasal mucus was collected by using one half of a 15 mm thin Merocel (Medtronic Xomed, Jacksonville, Fl. 130 
USA) for each nostril. The Merocels were placed in the nasal cavity for 20 minutes. Afterwards, they were 131 
centrifuged on 4500 rotations per minute at 25°C for 15 minutes. To determine the volume of nasal mucus, 132 
standardized 100 µl- and 10 µl-pipettes were used. Analyses of viscosity of nasal mucus were conducted by a 133 
plate rheometer (the Modular Compact Rheometer MCR 102, Anton Paar, Graz, Austria) with a CP25-1 measure 134 
plate at 37 °C. A 30 µl aliquot of the patient’s nasal mucus was placed on the rheometer plate to allow 135 
equilibration for 30 seconds at 37 °C, ensuring nearly in vivo conditions. A range of oscillatory frequencies – 136 
shear rates between 0.1 and 10’000 γ – was applied to the samples at a constant strain to measure viscosity. 137 





















sample. All measurements were directly conducted after mucus collection to minimize alterations in rheological 139 
characteristics.  140 
 141 
Sensitivity of the Nasopharynx 142 
The sensitivity of the nasopharynx was examined without local anaesthesia using a rigid 2 mm nasal endoscope 143 
(Karl Storz, Tuttlingen, Germany) coupled to an adapted 0.9 mm extension set normally used for arterial blood 144 
pressure measurements (Codan, Lensahn, Germany). This measuring instrument is illustrated in Figure 5. The 145 
extension set was connected to one of the apertures of a three-way cock. The second opening was connected to a 146 
Foley catheter (16 Charière, Teleflex , Athlone, Ireland). A syringe was connected to the third opening for the 147 
air supply. First, defined amounts of air (50 ml, 40 ml, 35 ml, 30 ml, 25 ml, 20 ml, 15 ml, 10 ml, 5 ml, 3 ml, 2 148 
ml) were filled into the Foley catheter. For each amount of air, the three-way cock was then opened in a way, 149 
that the defined amount of air was flowing from the Foley catheter only into the extension set and thereby to the 150 
end of the endoscope, which was placed 1cm in front of the nasopharynx. Using this method, a constant and 151 
defined flow of air could be ensured. Thereby, the smallest air volume, which surely could be sensed as an air 152 
puff, and clearly discriminated from the sensation of cold, was detected.   153 
 154 
Statistical Analyses 155 
Statistical analysis was performed using SPSS software version 25.0 (IBM, Armonk, NY, USA), and a two-sided 156 
P value of < 0.05 was considered significant. The normality of distribution was checked using the Kolmogorov-157 
Smirnov test. The Student t test was used to compare continuous variables, whereas Pearson x
2
 tests were 158 
performed for categorical data. For non-normally distributed continuous variables, a Mann-Whitney U test was 159 






















In total 30 patients – 15 PND and 15 healthy subjects – were assessed. The male/female ratio of the study 162 
population (n = 30) was 12/18 and the average age was 38.9 ± 15.0 years. Four patients with CRS and two with 163 
not active recurrent acute rhinosinusitis were included in our study population. Allergic rhinitis was seasonal and, 164 
apart from potentially associated PND symptoms, not active during examination in all patients assessed. Neither 165 
cystic fibrosis nor primary ciliary dysfunction were recorded in our study population. Furthermore, all patients 166 
undergoing functional lung tests showed no pulmonary impairment. Further demographic information is 167 
presented in Table 1. Parameters of interest could be obtained in all patients. Two STTs were not evaluable due 168 
to sniffing of the nose, despite exact instructions.  169 
Analyses of viscosity of nasal secretions at 1 rad/s as well as 100 rad/s showed significant differences in PND 170 
subjects compared to the control group (p < 0.001). Elevated viscosity was observed in 99.3% of PND patients. 171 
The median viscosity in PND patients was 8.41 ± 12.37 Pas at 1 rad/s or 0.11 ± 0.12 Pas at 100 rad/s and in 172 
controls 0.23 ± 0.75 Pas at 1 rad/s or 0.01 ± 0.02 Pas at 100 rad/s, respectively. Figure 1 and 2 demonstrates a 173 
more than ten times higher median of viscosity in PND subjects. Except for one, all of the other CRS patients 174 
clearly showed higher viscosity compared to non-CRS PND patients. Comparing the median viscosity, 175 
excluding PND patients with CRS, the PND median is still seven times higher compared to the control group 176 
(PND: 3.55 ± 3.93 Pas at 1 rad/s and 0.07 ± 0.04 Pas at 100 rad/s vs. Control: 0.23 ± 0.75 Pas at 1 rad/s and 0.01 177 
± 0.02 Pas at 100 rad/s). Two patients spontaneously reported improving PND symptoms. Therefore, we decided 178 
to retest these two individuals during an interval of decreasing or no symptoms. Follow-up measurements of 179 
viscosity in symptom-free episodes, one month after first examinations, showed similar values to healthy 180 
subjects (0.16 and 0.74 Pas at 1 rad/s and 0.003 and 0.01 Pas at 100 rad/s).  181 
The STT in PND patients was significantly prolonged compared to controls (p = 0.008). The median in PND 182 
was 17.0 ± 4.2 min whereas it was 11.1 ± 4.7 min in healthy individuals. Figure 3 depicts a delayed mucociliary 183 
clearance in 76.92% (11/13) of PND patients.  184 
The median air volume for an air puff sensation was 40 ± 19.0 ml in PND and 5 ± 11.8 ml in control subjects, 185 
which depicts significant differences in the nasopharyngeal sensitivity in PND patients compared to healthy 186 
individuals (p = 0.002) (Figure 4). In 60% of PND patients a hyposensitivity – defined as air volumes ≥35 ml for 187 





















The SPT displayed atopy in 25 patients (n = 30, 83.3%), 14 in the PND and 11 in the control group. No 189 
significant difference in atopy screening between cases and controls could be found (p = 0.367).   190 
The volume of nasal secretions was not increased in PND patients (p = 0.061). A trend for reduced volumes of 191 
nasal secretions in PND patients compared to healthy individuals could be seen, as the median volume of nasal 192 






















This study provides three important new findings concerning the pathophysiology of PND. First, the viscosity of 195 
nasal secretions is significantly higher in PND patients compared to a matched control group. Second, the 196 
mucociliary clearance towards the nasopharynx is decreased. Third, patients with PND showed reduced 197 
nasopharyngeal sensitivity.  198 
Viscosity was increased in 99.3% and mucociliary clearance was found to be delayed in 76.9% of PND patients. 199 
This has – to the best of our knowledge – never been demonstrated so far. Our findings disagree with Rimmer 200 
and colleagues’ hypothesis concerning mucosal rheology not being relevant in the pathophysiology of PND 
(2)
. 201 
We can clearly object their assumptions with direct evidence. The viscosity of nasal secretions under normal 202 
conditions is not well studied due to difficulties in obtaining adequate sample volumes. Hence most data are 203 
derived from samples obtained after provocation (methacholine, histamine, allergen), which could lead to 204 
differences in results 
(14)
. However, the rheological characteristics of unprovoked nasal secretions in some 205 
disease states have already been reported 
(6,7)
. Unfortunately, nasal secretions were not investigated under normal 206 
conditions or in PND patients. Nevertheless, they also encountered the problem of not being able to gather 207 
enough mucus from nasal cavities under unprovoked conditions in some disease states 
(6)
. Therefore, we used 208 
one half of a 15 mm thin Merocel – ensuring an almost unprovoked collection of nasal mucus – for appropriate 209 
analyses. In their work, a double-capillary type viscometer was used 
(6)
. Due to the advantage of changing shear 210 
rates over a wide range from 0.1 till 10’000 γ, allowing more precise measurements 
(7)
, we have chosen a plate 211 
type rheometer for our analyses. There are some disease states, e.g. CRS, non-allergic and allergic rhinitis as 212 
well as common cold, which result in an increased viscosity of nasal secretions 
(6)
. Patients suffering from the 213 
above mentioned diseases were analyzed in detail. In our study population, four patients suffered from CRS. 214 
Allergic rhinitis was seasonal and, apart from potentially associated PND symptoms, not active during 215 
examination in all patients assessed.  Since 33.3% of the controls also showed atopy for house dust mites, it is 216 
unlikely that atopy itself is largely relevant for PND symptoms. Except for one, all of the other CRS patients 217 
clearly showed higher viscosity compared to non-CRS PND patients. Comparing the median viscosity, 218 
excluding PND patients with CRS, at both 1 rad/s as well as 100 rad/s, the PND median is still seven times 219 
higher compared to the control group. As already described by others, viscosity of respiratory mucus can be 220 
altered by many factors, such as the degree of hydration, pH, the electrolyte concentration, types and quantity of 221 
mucins present, degree of its cross linking, alterations in electrostatic interactions among mucins, as well as 222 
polymer length, and the presence of extracellular material 
(15)
. The percentage of solids was also found to 223 
correlate with increased viscosity and elasticity 
(16)























, seems to be the major component for changes in mucus’ rheology in PND. We therefore believe that 225 
therapeutic interventions focusing on better hydration or liquefaction of nasal secretions might have an 226 
improving effect on PND symptoms. Furthermore, normalized rheological properties of mucus during a 227 
symptom-free interval is consistent with recently reported analyses for sputum of subjects with cystic fibrosis 228 
(16)
. The median values of nasal mucus viscosity in the present study are significantly lower than those of CRS 229 
patients found in the most recent report in literature, which used a cone-and-plate rheometer to analyze sinonasal 230 
mucus specimens 
(7)
. This discrepancy may be explained by several reasons. Our analysis was performed using 231 
centrifuged Merocels for mucus collection enabling enough amounts of unprovoked nasal mucus collections also 232 
in healthy subjects. Thus, the fixation of more viscous components of nasal mucus on Merocels after 233 
centrifugation could be possible. However, as long as this effect occurred in healthy as well as PND subjects, the 234 
significant difference in viscosity in those groups should not be affected. In contrast, others just included 235 
individuals whose nasal examination revealed collections of mucus within the nasal cavities to enable a mucus 236 
collection by a suction attached to a specimen trap 
(7)
. Furthermore, nasal mucus of their samples may be 237 
thickened due to long retention time in the nasal cavity. Our findings are not only novel but also unique in the 238 
way that even freshly produced anterior nasal secretions show significant differences in viscosity in PND 239 
subjects compared to healthy ones. Accordingly, the anterior part of the nose including the inferior nasal 240 
turbinate seems to be involved in PND’s pathophysiology.  241 
Own follow-up measurements of two PND patients during a symptom-free interval showed decreasing viscosity 242 
of nasal secretions, even within the range of control individuals. These findings support our hypothesis. 243 
The reduced mucociliary clearance in PND patients may be caused by inflamed mucosa and increased viscosity 244 
of nasal secretions, as viscosity and mucociliary clearance negatively correlates with each other 
(7,8)
. Due to the 245 
well-known fact of a delayed mucociliary clearance in smokers 
(18,19)
, smoking habits of all subjects were 246 
recorded. As all of our participants were non- or ex-smokers, smoking was no disturbing factor. The effect of a 247 
prolonged STT because of age 
(9)
 was eliminated by a matched control group. The influence of diabetes type 2 248 
on a prolonged STT 
(9)
 was not detectable, since diabetes type 2 was occurring in both groups. Arterial 249 
hypertension 
(9)
 might be a disturbing factor, as it is only represented in the PND group. However, only two PND 250 
subjects were suffering from arterial hypertension.  251 
As presented in Figure 4, nasopharyngeal sensitivity was reduced in 60% of PND patients. Rimmer and 252 
colleagues’ study showed similar findings by demonstrating that patients with PND, unlike healthy subjects, 253 





















saline in the nasal cavity to replicate postnasal drip 
(2)
. PND patients were even unable to perceive a very thick 255 
mucus secretion in the form of the 4% HPMC 
(2)
. In due consideration of assessed nasopharyngeal 256 
hyposensitivity in the current study, this might be derived from an altered sensory feedback caused by inflamed 257 
mucosa. Nevertheless, patients with PND often describe a sensation of fluid dripping or foreign body sensation 258 
in the throat, which could also be explained by a perceptual disturbance resulting from dysaesthesia. Another 259 
explanation may be, that postnasal drip secretion contains increased quantities of calcitonin gene related peptide 260 
and substance P, which are responsible for an altered sensation in the throat 
(20)
. Consecutively, elevated levels of 261 
these mediators could cause increased cough sensitivity in some of these patients, as well.  262 
Surprisingly, an inability to produce secretions in chronic rhinitics with PND symptoms has been described 
(21)
, 263 
which may also be explained by sensory dysfunction (hyperinnvervation/dysesthesia) rather than mucous 264 
hypersecretion as accounted for other reactive symptoms 
(22–24)
. These findings go in line with ours, since the 265 
median volume of nasal secretions in PND and healthy subjects was 120 µl and 340 µl, respectively. 266 
Consistently, the concept of PND due to an increased volume of secretions moving from the posterior nasal 267 
choanae into the posterior nasopharynx/oropharynx seems to be questionable. 268 
Our SPTs displayed atopy in 83.33% of all probands. Accordingly, neither the atopy nor the volume of nasal 269 
secretions appear to be largely relevant in PND symptoms, as they showed no significant differences in both 270 
groups.  271 
Since a relevant part of PND patients reported increasing symptoms during stressful periods, a psychological 272 
component in pathophysiology may also be involved and should be further investigated.  273 
However, based on our findings, viscosity seems to play a major role in the pathophysiology of PND as well as 274 
sensory dysfunction combined with prolonged mucociliary clearance. We believe these novel findings are of 275 
great importance going one step closer to understanding postnasal drip, as viscosity was found to be significantly 276 
increased in PND patients and decreasing in symptom-free intervals. Furthermore, this knowledge leads us to 277 
new therapeutic strategies such as the liquefaction of viscous nasal secretions in PND patients.  278 
The present findings of this analysis should be interpreted within the context of its strengths and limitations. It 279 
was an attempt to describe the pathophysiology of PND more precisely in a prospective case-control study. It 280 
was – to the best of our knowledge – the first and only analysis of viscosity and volume of unprovoked 281 
collections of nasal secretion, mucociliary clearance and nasopharyngeal sensitivity in PND patients. Our study 282 
showed clear and consistent findings in tested individuals. Due to the nature of this observational study, it is not 283 





















treatment effects. As pharyngeal sensitivity seems to be altered, it is almost impossible to find such correlations. 285 
However, to substantiate our findings larger studies with follow-up examination – ideally in symptom-free 286 
episodes or at least in episodes with reduced symptoms – in all patients are mandatory. What remains unclear is 287 
whether treatments altering the viscous properties of nasal secretions would result in improved mucociliary 288 






















In conclusion, the viscosity seems to be a major component of the pathophysiology of PND, since PND subjects 291 
significantly showed higher values of viscosity in nasal secretions compared to controls. Follow-up 292 
measurements in symptom-free intervals confirm these findings. Additionally, hyposensitivity/dysesthesia and a 293 
delay in mucociliary clearance may play a role in the mechanism of PND, as well. Earlier concepts of PND due 294 
to an increased volume of secretions and atopy do not seem to hold true since our analyses showed no significant 295 
difference between cases and controls. Based on our own findings, we suggest including liquefaction of viscous 296 
nasal secretions in PND treatment algorithms. This may not only improve PND but also chronic cough 297 
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TABLES  364 
Table 1: Demographic Information of Study Population     
Characteristics Postnasal Drip Control  P-Value  
Male / female (n = 30) 6 / 9 (40%/60%) 6 / 9 (40%/60%)  1.000  
Mean age (years) 39.27 ± 14.5 38.47 ± 15.9  0.838  
Sensitization / no sensitization 14 / 1 (93.33 %/6.67%)  11 / 4 (73.33%/26.67%)  0.367  
Mean number of sensitization 4.07 ± 3.08 3.60 ± 3.16  0.683  
Cough / No cough 
CRS / no CRS 
ARS / no ARS  
Smoker / non-smoker 
Mean number of medication 
Mean number of comorbidities 
7 / 8 (46.67%/53.33%) 
4 / 11 (26.67%/73.33%)  
2 / 13 (13.33%/86.67%) 
0 / 15 (0%/100%) 
1.47 ± 1.41 
1.67 ± 1.59 
0 / 15 (0%/100%) 
0 / 15 (0%/100%) 
0 / 15 (0%/100%)  
0 / 15 (0%/100%) 
0.93 ± 2.55 








Abbreviations: CRS = Chronic Rhinosinusitis, ARS = Recurrent Acute Rhinosinusitis  365 





















FIGURE LEGEND 367 
Figure 1: Significant difference in viscosity of nasal secretions at 1 rad/s between PND subjects and the controls 368 
(p < 0.001) 369 
Figure 2: Significant difference in viscosity of nasal secretions at 100 rad/s between PND subjects and the 370 
controls (p < 0.001)  371 
Figure 3: Significant difference in mucociliary clearance between PND patients and the controls (p = 0.008) 372 
Figure 4: Significant difference in sensitivity between PND patients and the controls (p = 0.002) 373 
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